ArrayExpress Gene Expression Atlas home | about the project | faq | feedback | blog | das | api new | help
CDX2 Homo sapiens
CDX2 is differentially expressed in 83 experiments [87 up/84 dn]: 41 organism parts: skeletal muscle [1 up/1 dn], white blood cells [0 up/1 dn], ...; 18 disease states: normal [5 up/2 dn], superficial transitional cell carcinoma with surrounding carcinoma in situ lesion [0 up/1 dn], ...; 20 cell types, 14 cell lines, 16 compound treatments and 16 other conditions.
Synonyms CDX2, CDX3
Orthologs pal-1 (Caenorhabditis elegans)  Cdx2 (Mus musculus)  cad (Drosophila melanogaster)  (Compare orthologs)
InterPro Term Helix-turn-helix motif, lambda-like repressor, Homeobox, Homeobox protein, Cdx, Homeobox, region, Homeodomain-related
GO Terms organ morphogenesis, sequence-specific DNA binding, transcription factor activity, transcription from RNA polymerase II promoter
Uniprot Q99626 
Search EB-eye ENSG00000165556
REST API
Expression Summary
157 factor values, click each to filter
Factor Value Factor Up/Down
Legend: - number of studies the gene is up/down in
Normal Disease state
2
5
None Compound treatment
1
1
FLAP Compound treatment
2
HNRPA2B Compound treatment
2
MK886 Compound treatment
2
Skeletal muscle Organism part
1
1
Homo sapiens Organism
2
Estrogen receptor 1 negative; ... Test result
1
1
Stromal cell Cell type
1
1
White blood cells Organism part
1
SW480 Cell line
1
SW620 Cell line
1
Pretreatment primary sample Clinical info
1
Glucocorticoid resistant Phenotype
1
Tumor Organism part
1
Superior cervical ganglion Organism part
1
Lung Organism part
1
HPL1 Cell line
1
Fetal bovine serum in media Growth condition
1
Smooth muscle Organism part
1
Osteoblast Cell type
1
Methotrexate Compound treatment
1
Chondrocyte Cell type
1
Vascular smooth muscle cell Cell type
1
Spermatid Cell type
1
HaCaT Cell line
1
Glucocorticoid sensitive Phenotype
1
CADO ES1 Cell line
1
Whole blood Organism part
1
Caudate nucleus Organism part
1
Thymus Organism part
1
Testis Organism part
1
Rapamycin Compound treatment
1
Spermatocyte Cell type
1
Cerebellum Organism part
1
Trigeminal ganglion Organism part
1
Postprandial lipid micelles in... Growth condition
1
ITS medium with albumin-bound ... Growth condition
1
ITS medium Growth condition
1
Inter-prandial lipid micelles ... Growth condition
1
Duodenum Organism part
1
Cartilage Organism part
1
Pons Organism part
1
Atrioventricular node Organism part
1
Lymphatic endothelial cell Cell type
1
Globus pallidus Organism part
1
MCF10A Cell line
1
MDA-MB-231 Cell line
1
Seminiferous tubule Organism part
1
Superficial transitional cell ... Disease state
1
Dimethyl sulfoxide Compound treatment
1
Bacterial endotoxin Compound treatment
1
Control Compound treatment
1
Atrial mycocardium Organism part
1
Ventricular myocardium Organism part
1
Wild_type Genotype
1
Enzo Labeling Protocol type
1
Placebo Compound treatment
1
Glutamine Compound treatment
1
Kidney Organism part
1
Peripheral blood Organism part
1
Macaca mulatta Organism
1
Training set Population
1
Test set Population
1
Trichostatin A Compound treatment
1
T84 Cell line
1
Caco-2 Cell line
1
Ciliary ganglion Organism part
1
Subthalamic nucleus Organism part
1
Mononuclear cell Cell type
1
Uterus Organism part
1
Prostate Organism part
1
CodeLink Labeling Protocol type
1
Beta cell islets Organism part
1
BT474 Cell line
1
Cingulate cortex Organism part
1
CD34+ Cell type
1
White blood cell Cell type
1
Platelet Cell type
1
Term Developmental stage
1
Midgestation Developmental stage
1
Heat-killed HL60 cell lysate Infection
1
Parietal lobe Organism part
1
Dorsal root ganglion Organism part
1
Kaposi's sarcoma-associated he... Infection
1
Baseline uninfected Disease state
1
Thyroid Organism part
1
Control RNAi
1
SIM2s RNAi
1
Temporal lobe Organism part
1
Acute promyelocytic leukemia Disease state
1
U937 Cell line
1
Breast carcinoma Disease state
1
Total_RNA Material type
1
Polysome-associated RNA Material type
1
Whole brain Organism part
1
N/a Test result
1
Plasma cell leukemia Disease state
1
MDA468 Cell line
1
Chronic lymphocytic leukemia Disease state
1
Non-ischemic cardiomyopathy Disease state
1
Immature monocyte derived dend... Cell type
1
IgV mutated Genotype
1
Not applicable Histology
1
Benign prostatic hyperplasia Disease state
1
Prostate carcinoma Disease state
1
Primary cells Cell line
1
PC3 Cell line
1
Monoclonal gammopathy of undet... Disease state
1
Drug-naive Clinical treatment
1
Primary Disease staging
1
Fetal lung Organism part
1
Endothelial cell Cell type
1
Fibroblast Cell type
1
IgV status unknown Genotype
1
Unknown_sex Sex
1
Hydrogen peroxide Compound treatment
1
Kaposi's sarcoma Disease state
1
5-aza-2'-deoxycytidine + trich... Compound treatment
1
Epithelial cell Cell type
1
Cyclosporin A, mycophenolate m... Clinical treatment
1
Sirolimus, mycophenolate mofet... Clinical treatment
1
Cerebellum peduncles Organism part
1
Measles virus Chicago-1 strain Infection
1
Uninfected Infection
1
Primary fibroblast Cell type
1
SkinEthic keratinocyte Cell type
1
Epidermal keratinocyte Cell type
1
Affymetrix Labeling Protocol type
1
PT1 Disease staging
1
Adrenal cortex Organism part
1
Lymph node Organism part
1
Pan troglodytes Organism
1
Malignant pleural mesothelioma Disease state
1
Mercaptopurine, methotrexate Compound treatment
1
Crohn's disease Disease state
1
Normal Histology
1
Vanadium pentoxide Compound treatment
1
Monocyte derived dendritic cel... Cell type
1
Skin Organism part
1
Ovary Organism part
1
Teratozoospermia Disease state
1
Normospermic Disease state
1
Cystic change Histology
1
Acute malaria, natural infecti... Disease state
1
PT3 Disease staging
1
T3aNxMx Disease staging
1
Organism_part Material type
1
Cell Material type
1
ERalpha transfected Genotype
1
ERbeta transfected Genotype
1
Superficial transitional cell ... Disease state
1
Pancreas Organism part
1
Fetal thyroid Organism part
1
Stage II Disease staging
1
Stage I Disease staging
1
Leydig cell Cell type
1
Expression Profiles
E-AFMX-5: Transcription profiling of human cell lines and tissues (GNF/Novartis)
Experimental Factors
Cell type Organism part Disease state
Show expression profile  /  experiment details

 
E-MEXP-1014: Transcription profiling of two human colon cancer cell lines treated with n-3 PUFA docosahexaenoic acid for 3 different time points
Experimental Factors
Show expression profile  /  experiment details

 
E-GEOD-5824: Transcription profiling of human Acute Lymphoblastic Leukemia CEM_C1 cells treated with rapamycin identifies rapamycin as a glucocorticoid resistance reversal agent
Experimental Factors
Phenotype Time Clinical info Dose Compound treatment
Show expression profile  /  experiment details

 
E-GEOD-412: Transcription profiling of human leukemia cells treated with mercaptopurine and/or methotrexate
Experimental Factors
Dose Compound treatment
Show expression profile  /  experiment details

 
Processing time: 0.105 secs.